• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.12% Nasdaq Up0.71%

    Neogenomics Inc. (NEO)

    4.75 Down 0.11(2.26%) Apr 24, 4:00PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Neogenomics Inc.
    12701 Commonwealth Drive
    Suite 9
    Fort Myers, FL 33913
    United States - Map
    Phone: 239-768-0600
    Fax: 239-690-4237
    Website: http://www.neogenomics.org

    Index Membership:N/A
    Industry:Medical Laboratories & Research
    Full Time Employees:440

    Business Summary 

    NeoGenomics, Inc., together with its subsidiary, NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company performs analyses for hematopoietic cancers, such as leukemia and lymphoma; and solid tumor cancers comprising breast, lung, colon, and bladder cancer. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry testing services to localize proteins in cells of a tissue section; and molecular testing services that focus on the analysis of DNA and RNA, as well as on the structure and function of genes at the molecular level. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Neogenomics Inc.

    Corporate Governance 
    Neogenomics Inc.’s ISS Governance QuickScore as of Jul 1, 2014 is 10. The pillar scores are Audit: 1; Board: 10; Shareholder Rights: 4; Compensation: 9.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Douglas M. VanOort , 60
    Exec. Chairman and Chief Exec. Officer
    Dr. Michael T. Dent M.D., 50
    Founder, Independent Director, Member of Audit Committee, Member of Compensation Committee and Member of Compliance Committee
    Mr. George A. Cardoza , 53
    Chief Financial Officer
    Mr. Steven C. Jones , 52
    Chief Compliance Officer, Exec. VP of Fin., Director of Investor Relations, Director and Chairman of Compliance Committee
    Dr. Maher Albitar M.D., 60
    Chief Medical Officer and Director of R&D
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders